HTR1A and Headache: Using ligand PET, e.g., a radioligand antagonist of 5-HT(1A) receptors ((18)F-MPPF), binding potential can reflect an increase in receptor density or a decrease in endogenous serotonin, which could explain the altered cortical excitability in headaches [55].